Literature DB >> 21683248

The role of autophagy in alpha-1-antitrypsin deficiency.

Tunda Hidvegi1, Amitava Mukherjee, Michael Ewing, Carolyn Kemp, David H Perlmutter.   

Abstract

In the classical form of alpha-1-antitrypsin (AT) deficiency, a mutant protein accumulates in the endoplasmic reticulum of liver cells, causing hepatic fibrosis and hepatocellular carcinoma by a gain-of-toxic function mechanism. Autophagy is specifically activated by the accumulation of mutant AT, and the autophagy plays a key role in intracellular degradation of this mutant protein. Our recent study indicates that an autophagy enhancer drug can decrease the hepatic load of mutant AT and reduce hepatic fibrosis in a mouse model of AT deficiency. In this chapter, we discuss what is known about autophagy in AT deficiency and methods for characterizing autophagy in cell lines and animal models.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21683248     DOI: 10.1016/B978-0-12-386471-0.00003-1

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  8 in total

Review 1.  Autophagy and cancer cell metabolism.

Authors:  Fred Lozy; Vassiliki Karantza
Journal:  Semin Cell Dev Biol       Date:  2012-01-18       Impact factor: 7.727

2.  Hsp104 facilitates the endoplasmic-reticulum-associated degradation of disease-associated and aggregation-prone substrates.

Authors:  Lynley M Doonan; Christopher J Guerriero; G Michael Preston; Teresa M Buck; Netaly Khazanov; Edward A Fisher; Hanoch Senderowitz; Jeffrey L Brodsky
Journal:  Protein Sci       Date:  2019-05-20       Impact factor: 6.725

3.  Antisense oligonucleotide treatment ameliorates alpha-1 antitrypsin-related liver disease in mice.

Authors:  Shuling Guo; Sheri L Booten; Mariam Aghajan; Gene Hung; Chenguang Zhao; Keith Blomenkamp; Danielle Gattis; Andrew Watt; Susan M Freier; Jeffery H Teckman; Michael L McCaleb; Brett P Monia
Journal:  J Clin Invest       Date:  2013-12-20       Impact factor: 14.808

4.  Histone deacetylase inhibitor (HDACi) suberoylanilide hydroxamic acid (SAHA)-mediated correction of α1-antitrypsin deficiency.

Authors:  Marion Bouchecareilh; Darren M Hutt; Patricia Szajner; Terence R Flotte; William E Balch
Journal:  J Biol Chem       Date:  2012-09-20       Impact factor: 5.157

5.  Heterozygosity of the Alpha 1-Antitrypsin Pi*Z Allele and Risk of Liver Disease.

Authors:  Aaron Hakim; Matthew Moll; Dandi Qiao; Jiangyuan Liu; Jessica A Lasky-Su; Edwin K Silverman; Silvia Vilarinho; Z Gordon Jiang; Brian D Hobbs; Michael H Cho
Journal:  Hepatol Commun       Date:  2021-04-03

6.  FBG1 Is the Final Arbitrator of A1AT-Z Degradation.

Authors:  John H Wen; Hsiang Wen; Katherine N Gibson-Corley; Kevin A Glenn
Journal:  PLoS One       Date:  2015-08-21       Impact factor: 3.240

7.  Erdj3 Has an Essential Role for Z Variant Alpha-1-Antitrypsin Degradation.

Authors:  Nazli Khodayari; George Marek; Yuanqing Lu; Karina Krotova; Rejean Liqun Wang; Mark Brantly
Journal:  J Cell Biochem       Date:  2017-06-20       Impact factor: 4.429

8.  The Mechanism of Mitochondrial Injury in Alpha-1 Antitrypsin Deficiency Mediated Liver Disease.

Authors:  Nazli Khodayari; Rejean L Wang; Regina Oshins; Yuanqing Lu; Michael Millett; Alek M Aranyos; Sayedamin Mostofizadeh; Yogesh Scindia; Tammy O Flagg; Mark Brantly
Journal:  Int J Mol Sci       Date:  2021-12-09       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.